Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study.

Similar findings were found for weight increase ≥5% and BMI increase ≥5% and ≥10% at 9 months post-index, although results did not reach statistical significance (the OR for a weight increase ≥10% was not evaluated due to the small sample size and large number of covariates included in the model, which resulted in lack of model convergence; Figure 3 ).

also in 111,027 other papers